Product sampling remains an invaluable tool in the pharmaceutical lifecycle, offering healthcare providers (HCPs) and patients a tangible opportunity to evaluate a therapy’s real-world safety, tolerability, and efficacy. However, the operational complexity—especially ensuring strict adherence to the Prescription Drug Marketing Act (PDMA) regula